Screening Strategies in Drug Discovery – News and Features

Researchers have developed a new method to determine if FDA-approved drugs could be repurposed or improved to help patients with a rare disease of the nervous system, Spinocerebellar ataxia type 5.

In this article, we consider what structural biology tells us and the techniques used to investigate it, the role of computation and how techniques can be used together to answer questions in a range of application areas.

Researchers have combined various artificial intelligence methods to enable the targeted design of molecules with specific properties,

This article will explore the importance of cell culture quality control and highlight recent developments in this area.

Organoids have revolutionized biological and medical research and proven to be excellent substitutes for animal models in preclinical studies. Here, we discuss what organoids are and how they have been developed over the years to become popular research tools.

In this interview, CEO of Arrayjet Dr. Iain McWilliam discusses advancements in modern microarray technology and the benefits that these tools can provide for high-throughput screening.

This article will discuss the development of cell lines for biotherapeutic production and will touch on key considerations, such as future manufacturability.

In this article, we look at the barriers preventing more widespread adoption of automation and digitization, and the opportunities they could bring.

For oncology, plant-based anti-cancer drugs have proven instrumental in the fight against a disease that claims approximately 609,360 lives in the United States alone. But their demand far outweighs their supply. Can yeast help?

This article will highlight the properties of an attractive drug target, outline the approaches used to identify targets and discuss the key steps involved in target validation.